![Michelle Rashford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Michelle Rashford
Società | Posizione | Inizio | Fine |
---|---|---|---|
RACE ONCOLOGY LIMITED | Direttore Tecnico/Scientifico/R&S | 01/07/2023 | - |
Storia della carriera di Michelle Rashford
Precedenti posizioni note di Michelle Rashford
Società | Posizione | Inizio | Fine |
---|---|---|---|
Kyowa Kirin, Inc. | Direttore Tecnico/Scientifico/R&S | 01/07/2020 | 01/10/2022 |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
![]() Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Direttore Tecnico/Scientifico/R&S | 01/09/2018 | 01/06/2020 |
Statistiche
Distribuzione geografica
Australia | 2 |
Cina | 2 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
![]() Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
Kyowa Kirin, Inc. |
- Borsa valori
- Insiders
- Michelle Rashford
- Esperienza